WHO-GMP Certified Commercial Pack · Product Code: AKP-072
Fluticasone Propionate 0.05% w/v Nasal Spray
Formulation Overview: Proven aqueous microsuspension intranasal glucocorticoid spray delivering precise 50 mcg metered doses to downregulate eosinophil-driven allergic mucosal edema. Formulated with Fluticasone Propionate BP / IP 0.05% w/v (0.05% w/v (50 mcg/spray)) in Metered-Dose Nasal Spray dosage form under Respiratory & Allergy, manufactured to IP / BP / USP Compendial standards and supplied in 120 Metered Sprays Glass/HDPE Atomizer Bottle with Dust Cap with complete eCTD/ACTD regulatory dossiers, Zone IVb stability, and batch CoA for African NRAs (NAFDAC, PPB, SAHPRA, TMDA, FDA Ghana) and global tenders.
| Item Code (SKU) | AKP-072 |
|---|---|
| Therapeutic Sector | Respiratory & Allergy |
| Dosage Form | Metered-Dose Nasal Spray |
| Active Ingredient | Fluticasone Propionate BP / IP 0.05% w/v |
| Strength / Purity | 0.05% w/v (50 mcg/spray) |
| Clinical Indication | Allergic rhinitis, non-allergic vasomotor rhinitis, and nasal polyp prophylaxis |
| Specification Standard | IP / BP / USP Compendial |
| Packaging Format | 120 Metered Sprays Glass/HDPE Atomizer Bottle with Dust Cap |
| Shelf Life | 24–36 Months |
| Storage Conditions | Store below 25°C; do not freeze; shake gently before use |
| Minimum Order Quantity | 1000 Packs |
| Regulatory / Analytical Docs | Full eCTD / ACTD Modules 1–5 + Zone IVb Stability Available |
| African & Global NRA Readiness | NAFDAC (Nigeria), PPB (Kenya), SAHPRA (SA), TMDA (Tanzania), FDA Ghana, AIRP, ARP, EFDA |
| Stock Availability | In Stock · Immediate Commercial Dispatch |
| Supply Status | Commercial Export Ready |